Literature DB >> 22307176

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

J Peveling-Oberhag1, G Crisman, A Schmidt, C Döring, M Lucioni, L Arcaini, S Rattotti, S Hartmann, A Piiper, W-P Hofmann, M Paulli, R Küppers, S Zeuzem, M-L Hansmann.   

Abstract

The precise molecular pathogenesis of splenic marginal zone lymphoma (SMZL) is still unknown. Clinical and epidemiological data suggest that chronic hepatitis C virus (HCV) infection may have an etiological role in a subset of cases.We performed a large-scale microRNA (miRNA) expression profiling analysis of 381 miRNAs by quantitative reverse transcription PCR (Q-RT-PCR) of 26 microdissected splenic tissue samples (7 HCV(+) SMZL; 8 HCV(-) SMZL and 11 non-neoplastic splenic controls). Single assay Q-RT-PCR and miRNA in situ hybridization (miRNA-ISH) were used to confirm the results in an independent cohort. Unsupervised hierarchical clustering of miRNA expression profiles demonstrated a distinct signature of SMZL compared with the normal splenic marginal zone. Supervised analysis revealed differentially expressed miRNAs, including miRNAs with previously recognized tumor suppressive or oncogenic potential. Five miRNAs were found significantly overexpressed in SMZL, including miR-21, miR-155 and miR-146a, whereas seven miRNAs showed significantly reduced expression, including miR-139, miR-345, miR-125a and miR-126. Furthermore, we identified miR-26b, a miRNA known to have tumor suppressive properties, as significantly downregulated in SMZL arising in HCV-positive patients (P=0.0016). In conclusion, there is a characteristic dysregulation of miRNA expression in SMZL with a possible implication in its molecular tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307176     DOI: 10.1038/leu.2012.29

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  40 in total

1.  Predictive value of microRNAs as novel biomarkers in detection of lymphoma.

Authors:  Yongjing Wang; Dianshui Sun; Juandong Wang; Aixia Dou; Chengyun Zheng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.

Authors:  Alessia Piluso; Laura Gragnani; Elisa Fognani; Elena Grandini; Monica Monti; Cristina Stasi; Elisabetta Loggi; Marzia Margotti; Fabio Conti; Pietro Andreone; Anna Linda Zignego
Journal:  Hepatol Int       Date:  2015-08-14       Impact factor: 6.047

Review 3.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 4.  Non-Hodgkin lymphoma and hepatitis C: where we are and what next?

Authors:  Mihály Sulyok; Mihály Makara; Eszter Újhelyi; István Vályi-Nagy
Journal:  Pathol Oncol Res       Date:  2014-10-02       Impact factor: 3.201

Review 5.  Hepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?

Authors:  Barbara Vannata; Luca Arcaini; Emanuele Zucca
Journal:  Ther Adv Hematol       Date:  2015-12-29

6.  Impact of DAA-Based Regimens on HCV-Related Extra-Hepatic Damage: A Narrative Review.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Antonio Russo; Mariantonietta Pisaturo; Clarissa Camaioni; Roberta Astorri; Nicola Coppola
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.

Authors:  Luca Arcaini; Davide Rossi; Marco Lucioni; Marta Nicola; Alessio Bruscaggin; Valeria Fiaccadori; Roberta Riboni; Antonio Ramponi; Virginia V Ferretti; Stefania Cresta; Gloria Margiotta Casaluci; Maurizio Bonfichi; Manuel Gotti; Michele Merli; Aldo Maffi; Mariarosa Arra; Marzia Varettoni; Sara Rattotti; Lucia Morello; Maria Luisa Guerrera; Roberta Sciarra; Gianluca Gaidano; Mario Cazzola; Marco Paulli
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

Review 8.  The hepatitis C virus infection as a systemic disease.

Authors:  Anna Linda Zignego; Laura Gragnani; Carlo Giannini; Giacomo Laffi
Journal:  Intern Emerg Med       Date:  2012-10       Impact factor: 3.397

Review 9.  MicroRNA expression in hepatitis C virus-related malignancies: A brief review.

Authors:  Laura Gragnani; Alessia Piluso; Elisa Fognani; Anna Linda Zignego
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 10.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.